secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001493152-24-020792
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition postpones extension vote to May 22; enters non-redemption agreements to limit trust redemptions
--------------------------------------------------------------------------------

- Extraordinary general meeting further postponed to 2:00 p.m. ET on May 22, 2024 to vote on extending business combination deadline to Feb. 17, 2025.
- Shareholders may submit or withdraw redemption requests by 5:00 p.m. ET on May 20, 2024 (same day as filing).
- Sponsor SRIRAMA Associates enters non-redemption agreements; for every 150,000 non-redeemed shares, sponsor transfers 50,000 Class A shares to agreeing shareholders.
- Non-redemption agreements aim to increase funds remaining in trust account after the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224020792/0001493152-24-020792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224020792/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer